Dr. Baehner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-7043Fax+1 415-353-7676
Education & Training
- University of California (San Francisco)Fellowship, Hematopathology, 2002 - 2003
- University of California (San Francisco)Fellowship, Cytopathology, 2001 - 2002
- University of California (San Francisco) School of MedicineFellowship, Selective Pathology, 2000 - 2001
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1997 - 2001
- University of Kansas School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2025
- FL State Medical License 2012 - 2014
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 1965 citationsThe evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen
Annals of Oncology. 2015-02-01 - 4350 citationsA Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerSoonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre B. Baker
The New England Journal of Medicine. 2004-12-30 - 87 citationsConsensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.Hadi Yaziji, Clive R. Taylor, Neal S. Goldstein, David J. Dabbs, Elizabeth H. Hammond
Applied Immunohistochemistry & Molecular Morphology. 2008-12-01
Journal Articles
- 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast CancerEleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
- Author Correction: Breast-Cancer-Specific Mortality in Patients Treated Based on the 21-Gene Assay: A SEER Population-Based StudyAnn G Schwartz, Charles F Lynch, Frederick L Baehner, Nature
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: